Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
posted on
Mar 27, 2020 11:08AM
***We are very busy at this time and simply do not have time for these types of responses.***
You imagine the outrageous arrogance of Resverlogixs' IR person/group!!!,,,This is their GD job to answer questions from shareholders and answer them professionally and to the best of thier ability. Such disregard, complacency and direct lack of respect to us must not be tolerated.
I hope to send a reactionary response to RVX Management in regards to their disrespect to Koos' simple question. The response is a finger in chest push back to all shareholders new and old! Very disheartening! jmo